Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation

American Heart Journal

Volumn 144, Issue 4, 2002, Pages 702-709

  Glover, Chris ^a   Ma, Xiaoli ^a   Chen, Yong Xiang ^a   Miller, Harvey ^a   Veinot, John ^a   Labinaz, Marino ^a   O’Brien, Edward ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; DECORIN; HISTONE H3; KI 67 ANTIGEN; MESSENGER RNA; PROTEOGLYCAN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHERECTOMY; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN METABOLISM; FEMALE; GENE OVEREXPRESSION; GLYCOPROTEIN SYNTHESIS; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; INTIMA; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTENOSIS; REVASCULARIZATION; RNA ANALYSIS; SMOOTH MUSCLE FIBER; THROMBOSIS;

EID: 0036791082     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2002.123577     Document Type: Article

References (47)

1. The EPISTENT Investigators. Randomised placebo-controlled and balloon-ongioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92.
2. Fischmon DL, Leon MB, Baim DS, et al. A randomized comparison of coronary artery stent plocement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331: 496-501.
3. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331: 489-95.
4. Mintz GS, Mehran R, Waksman R, et al. Treatment of in-stent restenosis. Semin Intervent Cardiol 1998;3:117-21.
5. Carrozza JP. In-Stent restenosis: should an old device treat a new problem? J Am Coll Cardiol 2000;35:1577-9.
6. Bauters C, Bonos J-L, Van Belle E, et al. Six-month ongiographic outcome after successful repeat percutaneous intervention for instent restenosis. Circulation 1998;97:318-21.
7. Eltchaninoff H, Koning R, Tron C, et al. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998;32:980-4.
8. Reimers B, Moussa I, Akiyama T, et al. Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis. J Am Coll Cardiol 1997;30:186-92.
9. Glover C, O'Brien ER. Pathophysiological insights from studies of retrieved coronary atherectomy tissue. Semin Intervent Cardiol 2000;5:167-73.
10. Kuntz RE, Baim DS. Prevention of coronary restenosis: the evolving evidence base for radiation therapy. Circulation 2000;101:2130-3.
11. Waksman R, Bhargava B, White L, et al. Intracoronary β-radiation theropy inhibits recurrence of in-stent restenosis. Circulotion 2000;101:1895-8.
12. Waksmon R, White L, Chan RC, et al. Intracoronary γ-irradiation therapy after angioplasty inhibits recurrence in patients with instent restenosis. Circulation 2000;101:2165-71.
13. Anderson PG, Bajaj RK, Baxley WA, et al. Vascular pathology of balloon-expandable flexible coil stents in humans. J Am Coll Cardiol 1992;19:372-81.
14. van Beusekom HMM, van der Giessen W, van Suylen RJ, et al. Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. J Am Coll Cardiol 1993;21:45-54.
15. Farb A, Sangiorgi G, Carter AJ, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
16. Komatsu R, Ueda M, Naruko T, et al. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation 1998;98:224-33.
17. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol 2000;35:157-63.
18. Moreno PR, Palacios IF, Leon MN, et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 1999;84:462-6.
19. Yutani C, Ishibashi-Ueda H, Suzuki T, et al. Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis. Cardiology 1999;92:171-7.
20. Strauss BH, Umans VA, vanSuylen RJ, et al. Directional atherectomy for treatment of restenosis within coronary stents: clinical, angiographic and histological results. J Am Coll Cardiol 1992;20: 1465-73.
21. O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primory and restenotic coronary atherectomy tissue: implications for anti-proliferative theropy. Circ Res 1993;73:223-31.
22. Veinot J, Ma X, Jelley J, et al. Preliminary clinical experience with the pullback atherectomy catheter and the study of proliferation in coronary plaques. Can J Cardiol 1998;14:1457-63.
23. Janqueira LCU, Bignolas G, Brentani RR, Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979;11:447-55.
24. Aikawa M, Rabkin E, Okada Y, et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechonism of lesion stabilization. Circulation 1998;97:2433-44.
25. O'Brien ER, Garvin MR, Stewart DK, et al. Osteopontin is synthesized by macrophage, smooth muscle and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994;145:883-94.
26. Bianco P, Fisher LW, Young MF, et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990;38:1549-63.
27. Riessen R, Isner J, Blessing E, et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries. Am J Pathol 1994;144:962-74.
28. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
29. O'Brien ER, Bennett KL, Garvin MR, et al. βig-h3, a TGF-β inducible molecule, is over-expressed in human coronary atherogenesis and restenosis. Arterioscler Thromb Vasc Biol 1996;16:576-84.
30. Carter AJ, Laird JR, Farb A, et al. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-405.
31. Marzluff WF, Pandey NB. Multiple regulatory steps control histone mRNA concentrations. Trends Biol Science 1988;13:49-52.
32. Chou MY, Chang ALC, McBride J, et al. A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization. Am J Pathol 1990;136:729-33.
33. Gown AM, Jiang J-J, Matles H, et al. Validation of the S-phase specificity of histone in situ hybridization in normal and malignant cells. J Histochem Cytochem 1996;44:221-6.
34. Alison M, Chaudry Z, Baker J, et al. Liver regeneration: a comparison of in situ hybridization for histone mRNA with bromode-oxyuridine labeling for the detection of S-phase cells. J Histochem Cytochem 1994;42:1603-8.
35. Brandl R, Richter T, Haug K, et al. Topographic analysis of proliferative activity in carotid endarterectomy specimens by immunocytochemical detection of the cell cycle-related antigen Ki-67, Circulation 1997;96:3360-8.
36. O'Brien ER, Glover C, Labinaz M, Initial experience with the flexicut directional coronary atherectomy catheter for the treatment of coronary in-stent restenosis. J Invasive Cardiol 2001;13:618-22.
37. Kearney M, Pieczek A, Haley L, et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997;95:1998-2002.
38. Pickering JG, Weir L, Jekanowski J, et al. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993;91:1469-80.
39. O'Brien ER, Urieli-Shoval S, Garvin MR, et al. Replication in restenotic atherectomy tissue. Atherosclerosis 2000;152:117-26.
40. Hanke H, Kamenz J, Hassenstein S, et al. Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting. Eur Heart J 1995;16:785-93.
41. Nikol S, Isner JM, Pickering JG, et al. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1582-92.
42. Yamakawa T, Bai H, Masuda J, et al. Differential expression of proteoglycans biglycan and decorin during neointima formation after stent implantation in normal and atherosclerotic rabbit aortas. Atherosclerosis 2000;152:287-98.
43. Fischer JW, Kinsella MG, Clowes MM, et al. Local expression of bovine decorin by cell-medioted gene transfer reduces neointimal formation after balloon injury in rats. Circ Res 2000;86:676-83.
44. O'Brien ER, Garvin MR, Dev R, et al. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994;145:883-94.
45. Rogers C, Welt FGP, Karnovsky MJ, et al. Monocyte recruitment and neointimal hyperplasia in rabbits: coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996;16:1312-8.
46. Rogers C, Edelman EB, Simon DI. A mAb to the B2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening afer angioplasty or sent implantation in rabbits. Proc Natl Acad Sci 1998; 95:10134-9.
47. Virmani R, Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol 1999;10:499-506.